Encontrado 1 documento, a visualizar página 1 de 1
Ordenado por
Data
ir para a página:
1
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definiti...
Aapro, MS; Van Wijk, FH; Bolis, G; Chevallier, B; Van der Burg, ME; Oliveira, CFBACKGROUND: Combination chemotherapy yields better response rates which do not always lead to a survival advantage. The aim of this study was to investigate whether the reported differences in the efficacy and toxicity of monotherapy with doxorubicin (DOX) versus combination therapy with cisplatin (CDDP) in endometrial adenocarcinoma lead to significant advantage in favour of the combination. PATIENTS AND METHO...
Data: 2003
|
Origem: Repositório do Centro Hospitalar e Universitário de Coimbra
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||